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Health in Africa
Time to wake up to cancer’s toll
Editor—As exemplified by your theme
issue on Africa of 1 October, cancer has
remained comparatively neglected in Africa
although increasingly prevalent: 70% of
people with cancer live in the economically
developing world, where by 2020 the annual
death toll is predicted to reach 20 million.1
In sub-Saharan Africa measures to pre-
vent cancer emphasised in the developed
world—such as smoking cessation and
screening—are not nationally adopted. One
third of African cancers are preventable, but
the influence of tobacco companies with mass
media advertising and high crop payments is
real. Traditional cancers, such as gastric and
hepatocellular carcinoma, and newer cancers,
such as lung cancer, breast
cancer, and AIDS related
Kaposi’s sarcoma, are increas-
ing in incidence.2 3
Patients’ expectations for
oncological treatment are low
in Africa. Lack of money, or a
concern not to place their fam-
ily in debt, prevents many from
seeking medical help.4 Lack of
awareness of predisposing fac-
tors, warning symptoms or
signs of cancer, or treatment
options mean that patients
present late. Cost and difficulty
of travel over rough terrain also
discourage service use. After diagnosis patients
may tend to look for peace of mind and
spiritual comfort rather than a physical cure.
In Africa disease modifying cancer treat-
ment and basic control of symptoms are
largely absent. Even when analgesia is avail-
able, patients with cancer may experience
severe and inadequately managed pain, as
health professionals underprescribe strong
analgesics, fearing drug dependency.5
Individual sub-Saharan countries cannot
tackle the challenges of cancer in isolation. A
new, cooperative approach and research base
are being advocated for preventing, treating,
and palliating cancer to bridge the gap
between developed and developing nations.5
Scott A Murray reader
scott.murray@ed.ac.uk
Elizabeth Grant research fellow
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Faith Mwangi-Powell executive director
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British mental health trust twins with
psychiatric service in Sierra Leone
Editor—Barnet, Enfield, and Haringey
Mental Health NHS Trust has formally
twinned with mental health services in
Sierra Leone.1 This small
project, currently funded by
UNISON trade union, aims
to provide regular, annual,
in-service training pro-
grammes for staff at Kissy
Mental Hospital, Freetown,
and other health workers and
trainees in Sierra Leone.
The programme is formally
supported by the British
High Commission in Free-
town, and the first delega-
tionof trust staff drawn from
various disciplines and some
originating from Sierra Leone
and other parts of west Africa will travel to
Freetown next month.
We hope to learn from this programme
as much as our colleagues in Sierra Leone
hope to learn from us. The population in
parts of the trust has a high proportion
of refugees affected by war in their
country of origin, including those of west,
central, and the Horn of Africa. And we
hope to help our colleagues in Sierra
Leone develop sustainable mental
health services provided by themselves,
rather than depending on the short term
interventions of non-governmental
organisations.
Shaun Collins assistant director
Child and Adolescent Mental Health, Barnet,
Enfield, and Haringey Mental Health NHS Trust
shaun.collins@beh-mht.nhs.uk
Competing interests: None declared.
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In Taiwan, taking action on road safety
made a difference
Editor—Ten years ago Taiwan was a
developing country like many in Africa with
a high mortality due to road traffic injuries.1
Mortality due to road crashes was stable at
7500 people a year from 1990 to 1995. It
dropped from about 7500 in 1995 to 4300
in 2003—a 42.7% decrease in nine years.
Various reasons led to this result, the most
important factor having been vigorous gov-
ernment policies and campaigns relating to
traffic safety. These include:
x 1994 Enforcement of helmet use in
Taipei City
x 1997 Implementation of helmet law
x 1998 Implementation of an emergency
medical system
x 1999 Enforcement of regulations on
wearing seat belts and not using cell phones
while driving and strict prohibition of drink-
ing and driving
x 2001 Campaign to use safety seats for
children.
An active policy taken by the govern-
ment was essential in improving road safety.
The efforts of people from many sectors and
disciplines, including public health profes-
sionals, healthcare providers, road and
motor vehicle engineers, law enforcement
officials, and educators, are crucial.
Min-Huei Hsu consultant neurosurgeon
Taipei Municipal Wanfang Hospital, No 111, Sec 3,
Shinglung Road, Taipei City, Taiwan 116
701056@tmu.edu.tw
Yu-Chuan Li chief, Graduate Institute of Medical
Informatics
Wen-Ta Chiu vice president
Taipei Medical University, Taipei, Taiwan
Competing interests: None declared.
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It’s time for good guidelines on health
financing practice
Editor—The intervention of global organi-
sations in the public health systems of
African countries1 2 is a form of research
involving humans and should be subject to
the Declaration of Helsinki and good
clinical practice guidelines.3 4
In structural reforms, global organisa-
tions (the investigators) work to convince the
governments of countries (legal representa-
tives of the study subjects) to take part in
health financing reforms (or policy experi-
ments, the new “medical” procedure). Since
the health consequences of the interven-
tions are largely unknown and the outcomes
are used as a basis of an evidence base, these
policy interventions are a form of experi-
Letters
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mentation (medical research) and should be
subject to the same scrutiny as other studies.
But they fall far short.
The Declaration of Helsinki is infringed
from the main consideration being related
to financial outcomes rather than the
wellbeing of the human subjects (reduced
government budget deficit is a poor
surrogate marker of the real health out-
comes), to the conflicts of interest arising
from the dependency relations between the
global institutions and the national govern-
ments such that the volunteers give “consent
under duress” in the light of the financial
inducements to participate. Also, when gov-
ernments lack suitable expertise, these
volunteers “cannot give or refuse consent
for themselves.”
Other failings are evident in the lack of
an independent ethical review and the
equivalent of an independent data monitor-
ing and safety committee. Furthermore, a
compensation mechanism should exist for
subjects who find themselves worse off as a
result of their participation in the experi-
ment. Yet the organisations recommending
or even imposing the reforms take no finan-
cial or moral liability for any unfavourable
outcomes, rather leaving it to the govern-
ments to take care of the consequences.
Douglas E Ball associate professor
Department of Pharmacy Practice, Faculty of
Pharmacy, Kuwait University, Kuwait
dball@hsc.edu.kw
Competing interests: None declared.
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Let’s learn from the success stories from
other poor countries . . .
Editor—Why is it that donor agencies and
policy advisers continue to ignore success
stories from poor countries such as Sri
Lanka?1 Together with Cuba, Costa Rica,
and Kerala in India, Sri Lanka’s achieve-
ments have been exemplary. Much has been
written about these models, but rarely are
there attempts to replicate them in develop-
ing countries.2 Are they out of date or are
they too alien to even consider?
Saroj Jayasinghe associate professor
Faculty of Medicine, University of Colombo,
Sri Lanka
sarojoffice@yahoo.com
Competing interests: None declared.
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. . . and get back to basics
Editor—More of the same will not ease
Africa’s health crisis.1 As an African with
training and work experience in interna-
tional health, I think that we need to go back
to basics.
Reducing poverty may be a starting
point. However, when it comes to rational
use of the meagre monetary resources in
sub-Saharan Africa, inefficient management
of resources and corruption become serious
stumbling blocks. Granted that corruption is
almost worldwide, its rampant nature in
Africa causes problems with monies avail-
able, received, and disbursed by the appro-
priate agencies in some countries.2
As to efficient use of meagre resources,
some countries outside Africa (for example,
Jamaica) that are in the same developmental
bracket as some African countries do far
better with less.3 The general determinants
of the health of populations show that an
efficient, robust, and performing health
services organisation is basic to the health of
nations.4 Human capacity building, as the
mainstay of all organisations, especially for
health service delivery, research, etc, has suf-
fered in most African countries, more so in
recent times from net migration from
sub-Saharan Africa to the developed world
(or much wealthier developing countries).5
Sub-Saharan African governments and their
developed counterparts need to work hard
together to find pragmatic solutions to the
brain drain problem.
The health crisis in Africa will continue
to be more of the same, unless we seriously
tackle the underlying issues driving the
crisis.
Albert M E Coleman associate specialist psychiatrist
Greenacres Community Mental Health Trust,
Worthing and Southlands Hospitals NHS Trust,
Worthing, West Sussex BN11 2DH
albert.coleman@gmail.com
Competing interests: None declared.
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Medical brain drain is a consequence of
bad policy
Editor—The medical brain drain is not
new.1 During my undergraduate medical
education in Africa, most of our lecturers
had at some stage trained abroad. Our
impression was that standards were better in
Europe and America. Attached to this was a
clear message that if you wanted to be the
best, experience abroad was crucial. Experi-
ence in Europe or America conferred a spe-
cial status on doctors as most government
funded hospitals relied on such doctors to
draw on their new experiences to improve
local standards.
Apart from the obvious training ben-
efits, the opportunity to earn a good income
for a limited period was too good for many
to pass up. To think that the brain drain hap-
pens purely for financial and economic ben-
efits is, however, an over-simplification. The
key is the inability to maintain a “migration
equilibrium.”
In the past, doctors who left Africa
returned proud of their experience and
newly found status, more fulfilled, and keen
to pass on their knowledge. They were
happy to work in less well funded but never-
theless safe environments.
Years of underinvestment in the health
sector, poor management of resources, and
government malaise have eroded the previ-
ously high standards in many institutions.
Doctors returning quickly find that the
working environment is not safe, and word
spreads quickly.
The prospect of moving to a better envi-
ronment and living a more fulfilled life tran-
scends professions or origin. The key to
retention in Africa is to make people feel
valued and create an environment where
doctors can feel fulfilled in doing what they
do best—saving lives.
Gbola O Sangosanya specialist registrar
Chelsea and Westminster Hospital, London
SW10 9NH
gosango2003@yahoo.co.uk
Competing interests: GOS was trained in Africa
and is currently working in the UK.




Editor—Colquitt et al recently published a
health technology assessment on the clinical
and cost effectiveness of continuous subcu-
taneous insulin infusion for diabetes for the
National Institute for Health and Clinical
Excellence (NICE).1 Believing that some
important issues needed to be communi-
cated with other readers, we contacted the
NHS Health Technology Assessment Pro-
gramme and were informed that its journal
does not offer the opportunity to respond to
previous appraisals in forthcoming publica-
tions (although the programme’s website
offers a forum for discussion, at
www.ncchta.org/correspond/).
Given the potential impact of such pub-
lications in the United Kingdom and
beyond, this approach caused us concern, as
we believe that the website discussion would
reach only a limited audience. We here out-
line certain shortcomings of the assessment
by Colquitt et al.
Colquitt et al based their findings on a
literature review made before August 2002
(published in October 2004), at which time
no published cost effectiveness analyses on
continuous subcutaneous insulin infusion v
multiple daily injections of insulin existed.
The authors said that they were unable to
identify health outcomes that can be quanti-
fied for the purposes of cost effectiveness
analysis, particularly in terms of translating
observed benefits for glycaemic control into
costs per quality adjusted life year (QALY)
gained. However, publications on at least
four health economic models that are able
to project the long term change in risk of
Letters
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complications dependent on concentrations
of glycated haemoglobin, and thereby calcu-
late clinical and cost outcomes, were
available at that time.2–5 Since the comple-
tion of the review, at least five other peer
reviewed diabetes models have been pub-
lished that can project cost effectiveness on
the basis of changes in glycated haemo-
globin, and two further studies have actually
examined the cost effectiveness of imple-
menting continuous subcutaneous insulin
infusion v multiple daily injections of insulin
treatment in the UK, both reporting
attractive incremental cost effectiveness
ratios (see longer version of this letter).
Colquitt et al did not seek further
consultation from competent health eco-
nomic modelling groups with experience in
diabetes before publishing their report. If
they had they would have been unlikely to
conclude that they had not found a satisfac-
tory method, in the time available, of
converting observed benefits into a cost per
QALY. A method has been available for
some time and, in the years between
completion of the review and its publication,
several transparent, validated, and generally
well accepted computer simulation models
of diabetes have been described in the medi-
cal press (see longer version of this letter).
Andrew J Palmer director, medical research
ap@thecenter.ch
Daniel M D Tucker health economist
Joshua A Ray health economist
William J Valentine health economist
CORE—Centre for Outcomes Research,
Buendtenmattstrasse 40, 4102 Binningen,
Switzerland
Craig Currie honorary research fellow in diabetes,
endocrinology, and metabolism
Department of Medicine, Cardiff University,
University Hospital of Wales, Cardiff CF14 4UJ
Phil McEwan director
School of Mathematics, Cardiff University, Cardiff
CF14 4UJ
Michael Brändle director
Division of Endocrinology and Diabetes,
Department of Internal Medicine, Kantonsspital St
Gallen, Switzerland
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Data need to be accurate when
screening for depression in
teenagers
Editor—With reference to Lenzer’s news
article,1 one of the problems with promotion
of universal mental health screening of
children—and a good reason for many peo-
ple’s suspicions of another agenda—is the
often inflated numbers cited. For example,
the TeenScreen website notes that one in 10
American children and adolescents experi-
ence mental illness and impairment, but
only one in five receives treatment.2 The
source cited is a US Surgeon General’s
report from 2001—in support of a “National
Action Agenda on Children’s Mental
Health.”3
Yet the US Centers for Disease Control
(CDC) reports that in 2001-3, 5% of Ameri-
can children aged 4-17 had emotional or
behavioural difficulties, based on over
10 000 national health interview surveys.
The CDC also reports that these difficulties
had an impact on functioning in 80%—in
other words, 4% of the total, substantially
lower than the 10% cited by TeenScreen and
perhaps not the “public crisis in mental
health for children and adolescents” that the
Surgeon General’s report claimed.3 4
The CDC also reports that in 2003, 65%
of children aged 4-17 with emotional or
behavioural difficulties received some type
of mental health service for their problem,
with 45% receiving help from a mental
health professional and 40% from a general
physician.5 Again, this is substantially differ-
ent from the 20% treatment rate cited by
TeenScreen.2
Joan McClusky medical writer
New York, NY 10003, USA
jmcclusky@medimedia.com
Competing interests: None declared.
1 Lenzer J. US teenager’s parents sue school over depression
screening test. BMJ 2005;331:714. (1 October.)
2 Columbia University TeenScreen Program. Setting the
record straight about TeenScreen. www.teenscreen.org/
cms/content/view/107/139/ (accessed 6 Oct 2005).
3 Office of the Surgeon General. Surgeon general releases a
national action agenda on children’s mental health.
www.hhs.gov/surgeongeneral/news/pressreleases/
pressreleasechildren.htm (accessed 6 Oct 2005).
4 Centers for Disease Control and Prevention. U.S. children
with emotional and behavioral difficulties: data from the
2001, 2002, and 2003 national health interview surveys.
www.cdc.gov/nchs/data/ad/ad360.pdf (accessed 6 Oct
2005).
5 Centers for Disease Control and Prevention. QuickStats:
percentage of children aged 4-17 years with emotional or
behavioral difficulties* who used mental health services, by
type of service—United States, 2003. www.cdc.gov/mmwr/
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Europe in transition
Biomedical research from eastern
Europe may be under-represented
Editor—The unique database of ISI (Insti-
tute of Scientific Information) has well
known limitations in assessing biomedical
research.1 The most important one is that its
content mainly reflects the mostly English
language pool of the “international jour-
nals.” Some European non-English speaking
countries, and especially east European
countries, have a strong tradition of publish-
ing in their native languages. This pool of
publications is not closely connected to the
one reflected in the ISI database.
The “quality” of research products
published in local journals may be disputed,
but the quantity or research input of east
European countries is underestimated in the
study by Soteriades and Falagas.1
Vasiliy Vlassov director
Russian Branch of the Nordic Cochrane Centre,
Cochrane Collaboration, PO Box 13, Moscow
109451, Russia
vlassov@cochrane.ru
Competing interests: None declared
1 Soteriades ES, Falagas ME. Comparison of amount of
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Dietary fat is not the villain
Editor—Zatonski and Willett claim that a
decrease of saturated fat and an increase of
polyunsaturated fat consumption explain
the decrease of coronary heart disease in
Poland.1 However, ecological data are prone
to bias because they are rarely, if ever,
adjusted for confounders. In this case they
are even contradicted by similar studies in
the past. In a review including 103 time
periods in 35 countries, I found that in 30
time periods an increased intake of satu-
rated fat was followed by increased coronary
mortality, but after 29 other periods with
increased saturated fat consumption heart
mortality was unchanged in six and
decreased in 23.2
Zatonski’s and Willett’s statement that
their finding is supported by epidemiologi-
cal and clinical evidence is not true either. In
a review of all cohort and case-control stud-
ies, heart patients had eaten more saturated
fat than had healthy controls in three
cohorts, but in one cohort they had eaten
less, and in 22 cohorts and in six
case-control studies no difference was
found.2 No cohort study or case-control
study has found that coronary patients have
eaten fewer polyunsaturated fats either; on
the contrary, three cohort studies found that
they had eaten more than the healthy
controls, and in 29 studies no difference was
found.2
The absence of an association between
fat intake and coronary disease was recently
confirmed in a large Swedish population
study.3 No association has been found either
between intake of dietary fats and degree of
atherosclerosis at necrotopsy.2 Most impor-
tantly, two meta-analyses of all controlled,
randomised dietary trials, in which the only
type of intervention was a lowering of
dietary saturated fats and an increase of
dietary polyunsaturated fats, found that the
total number of deaths was identical in the
treatment and the control groups.2–5
Uffe Ravnskov independent researcher
Magle Stora Kyrkogata 9, 22350 Lund, Sweden
ravnskov@tele2.se
Competing interests: None declared.
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A longer version of this letter including all
references is available at http://bmj.com/cgi/
eletters/324/7339/705[118511
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HIV risk environment in Hungary is
different from that in Russia and west
Balkan states
Editor—In Hungary the HIV risk environ-
ment is not quite as severe as in Russia
and the west Balkans, and the macro-
environmental (especially economic and
social) components are not the same.1 Hun-
gary did not experience the rapid changes in
its population; the collapse of its healthcare
and welfare systems; or the precipitous eco-
nomic, social, and cultural crises that took
place in Russia. Hungarian
drug policy, which contains
elements of harm reduction,
will also contribute to pre-
venting the massive spread
of infectious diseases. For
example, qualitative studies





and the help of needle
exchange programmes
(which are, however, avail-
able only in bigger cities).2
Although the HIV prevalence is zero
among injecting drug users, the prevalence
of hepatitis C is about 30-35%. According to
our experience, the HIV testing is wide-
spread, but the opportunities for testing for
hepatitis C virus are limited: either in
abstinence oriented drug clinics or low
threshold services. Opportunities for testing
need to be improved urgently, and the
coverage of the low threshold services in
connection with injecting drug users needs
to be increased.3
József Rácz researcher, psychiatrist
Institute for Psychology, Victor Hugo 18-22,
Budapest-1132, Hungary
raczj@t-online.hu
Competing interests: None declared.
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Summary of webchat
The aim of the theme issue of Europe
in transition was to give a snapshot of coun-
tries in political and economic transition.
Participants in the accompanying webchat
discussed problems that they were facing in
the course of their own work, analysed
where these problems might stem from, and
thought of some tentative solutions.1
The problems mentioned included the
deterioration in health and social services
since the collapse of the communist system
in eastern Europe. The opportunity to study
prospectively what is possibly the biggest
system reform in our time was missed
because the pressure to deliver changes
overnight was so strong that a more system-
atic, planned, and reasoned approach
seemed to equal sabotage. Money was spent
on reforms but without monitoring because
of this pressure. Consequently, baseline data
to measure progress and impact of reform
are hardly available, although UNICEF’s
TransMonee database was mentioned as a
resource.
Human resources were also identified as
a problem—not because of a lack of trained
people but because of attitudinal or financial
problems, political conflicts of interest, a lack
of practical skills, and a lack of incentives. A
lack of money was identified as a hindrance
to progress by some, but a lack of knowledge
of how to use existing
resources most effectively was
probably worse. An absence of
individuals’ responsibility for
their health—another
problem—may be a legacy of
communism. Scarce finances
affect preventive health meas-
ures, such as screening pro-
grammes, which have deterio-




problems in their countries
seriously and whether years
under communist rule might have created
an aversion to solving problems collectively.
Suggested solutions to this array of
problems included capacity building and
pan-European health programmes. Provid-
ing governments with unbiased inter-
national decision support or opportunities
to work with international bodies may
help because small collaborative pilot
projects have already been found to be
effective.
Funding and government support were
seen as perennial problems, although joint
international applications from academic
partners were regarded as having a chance
of success. Good epidemiological and
economic studies could help to provide a
common focus. The health agenda needs to
be supported at the overall political level,
not just by sectoral bodies, and the
population and healthcare providers were
called on to change their thinking to enable
reform, which requires a major change in
values and taking responsibility for one’s
own health. Central and local governments
need to collaborate better. Central govern-
ments should set standards and monitor
progress, while local governments, better
informed about local needs and conditions,
should set strategies.
How might the BMJ help? It could invite
contributions from the region, especially
from those studying problems across coun-
tries, and it could lead training courses on
publishing papers there. Perhaps another
theme issue on transition economies could
be published in a year’s time as part of a
continuing process of monitoring progress.
A similar online discussion for policy
makers and another webchat covering one
specific public health topic could also be
useful.
Birte Twisselmann assistant editor (web)
BMJ
Competing interests: None declared.
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Ignore fairy tales when
campaigning for NHS reform
Editor—I find it hard to see why the Poet
Laureate or Philip Pullman has anything
useful to say about NHS reform.1 However
good their writing (and it is), their views of
the NHS are mere fairy tales.
The “collaborating network” so threat-
ened by competition doesn’t exist. The NHS
that I know has good parts, but other parts
lose your medical records when you move
from unit to unit, fail to eliminate bad medi-
cal practice, and have consultants whose
rivalry over who gets patients into beds is a
serious barrier to running the hospital
efficiently.
As for the “planned and equitable” way it
delivers care to patients: in the real world,
centrally planned economies are a total fail-
ure because the incentive to improve is com-
pletely dominated by the incentive to be
uniform. Competition creates a sufficiently
powerful incentive to improve how things
are organised that the long term benefit to
all is far greater than the apparent
inefficiency of competition.
But the most absurd statement of all is
the idea that “growth in paperwork” is eating
into “scarce funding.” How any organisation
where spending has doubled in a mere dec-
ade could consider funding “scarce” is rich
enough. But the idea that all management
activity is parasitic on the hardworking
medical staff (which is what the jibe about
paperwork implies) is another fairy tale. The
real NHS isn’t like that. It’s under-managed
and badly organised, and putting good
managers in place can often dramatically
improve the capacity of the medical staff to
treat patients.
The underlying assumption behind the
opposition to reform is that the current
NHS is as good as it can be and there is no
way to do it better. There is legitimate debate
about how to do better, but starting with a
fairy tale view of how the NHS is now is not
a good place to start.
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